Your browser doesn't support javascript.
loading
Effect of FAK inhibitor VS-6063 (defactinib) on docetaxel efficacy in prostate cancer.
Lin, Hui-Ming; Lee, Brian Y; Castillo, Lesley; Spielman, Calan; Grogan, Judith; Yeung, Nicole K; Kench, James G; Stricker, Phillip D; Haynes, Anne-Maree; Centenera, Margaret M; Butler, Lisa M; Shreeve, S Martin; Horvath, Lisa G; Daly, Roger J.
Afiliación
  • Lin HM; Cancer Division, The Kinghorn Cancer Centre/Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
  • Lee BY; St Vincent's Clinical School, The University of New South Wales, Darlinghurst, New South Wales, Australia.
  • Castillo L; Cancer Division, The Kinghorn Cancer Centre/Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
  • Spielman C; Cancer Division, The Kinghorn Cancer Centre/Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
  • Grogan J; Cancer Division, The Kinghorn Cancer Centre/Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
  • Yeung NK; Cancer Division, The Kinghorn Cancer Centre/Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
  • Kench JG; Cancer Division, The Kinghorn Cancer Centre/Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
  • Stricker PD; Cancer Division, The Kinghorn Cancer Centre/Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
  • Haynes AM; Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
  • Centenera MM; Australian Prostate Cancer Research Centre-NSW, Darlinghurst, New South Wales, Australia.
  • Butler LM; Cancer Division, The Kinghorn Cancer Centre/Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
  • Shreeve SM; St Vincent's Clinical School, The University of New South Wales, Darlinghurst, New South Wales, Australia.
  • Horvath LG; Australian Prostate Cancer Research Centre-NSW, Darlinghurst, New South Wales, Australia.
  • Daly RJ; St Vincent's Prostate Cancer Centre, Darlinghurst, New South Wales, Australia.
Prostate ; 78(4): 308-317, 2018 03.
Article en En | MEDLINE | ID: mdl-29314097
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirazinas / Sulfonamidas / Benzamidas / Neoplasias de la Próstata Resistentes a la Castración / Docetaxel / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Prostate Año: 2018 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirazinas / Sulfonamidas / Benzamidas / Neoplasias de la Próstata Resistentes a la Castración / Docetaxel / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Prostate Año: 2018 Tipo del documento: Article País de afiliación: Australia